Cargando…
Intracavernous Injection of Autologous Platelet-Rich Plasma Ameliorates Hyperlipidemia-Associated Erectile Dysfunction in a Rat Model
INTRODUCTION: Hyperlipidemia is associated with an increased risk of erectile dysfunction (ED) mediated by endothelial damage. Platelet-rich plasma (PRP) contains numerous angiogenic growth factors. Currently, evidence supporting the use of PRP for ED treatment is limited. AIM: We investigated PRP i...
Autores principales: | Huang, Yun-Ching, Wu, Chun-Te, Chen, Miao-Fen, Kuo, Yi-Hung, Li, Jhy-Ming, Shi, Chung-Sheng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8072173/ https://www.ncbi.nlm.nih.gov/pubmed/33529811 http://dx.doi.org/10.1016/j.esxm.2020.100317 |
Ejemplares similares
-
Intracavernous Injection of Platelet-Rich Plasma Therapy Enhances Erectile Function and Decreases the Mortality Rate in Streptozotocin-Induced Diabetic Rats
por: Liao, Chun-Hou, et al.
Publicado: (2022) -
Recurrent transient global amnesia after intracavernous Caverject injection in erectile dysfunction after robotic prostatectomy
por: Maffei, D., et al.
Publicado: (2020) -
Intracavernous injection of size-specific stem cell spheroids for neurogenic erectile dysfunction: Efficacy and risk versus single cells
por: Xu, Yongde, et al.
Publicado: (2020) -
Short-term intracavernous self-injection treatment of psychogenic erectile dysfunction secondary to sexual performance anxiety in unconsummated marriages
por: Lidawi, Ghalib, et al.
Publicado: (2021) -
Intracavernous administration of bone marrow mononuclear cells: a new method of treating erectile dysfunction?
por: Ichim, Thomas E, et al.
Publicado: (2013)